Efficacy and safety of continuous 4-year telbivudine treatment in patients with chronic hepatitis B

by Wang Y., Thongsawat S., Gane E.J., Liaw Y.-F., Jia J., Hou J., Chan H.L.Y., Papatheodoridis G., Wan M., Niu J., Bao W., Trylesinski A., Naoumov N.V.
Published 2014

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B

by Zeuzem, S., Gane, E., Liaw, Y.-F., Lim, S.G., DiBisceglie, A., Buti, M., Chutaputti, A., Rasenack, J., Hou, J., O'Brien, C., Nguyen, T.T., Jia, J., Poynard, T., Belanger, B., Bao, W., Naoumov, N.V.
Published 2016

Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma

by Omata, M., Tateishi, R., Yoshida, H., Shiina, S., Lesmana, L.A., Budihusodo, U., Lesmana, C.R., Chen, P.-J., Lin, S.-M., Liaw, Y.F., Kudo, M., Lee, J.M., Choi, B.I., Poon, R.T.P., Cheng, A.L., Jia, J.-D., Obi, S., Han, K.H., Jafri, W., Chow, P., Lim, S.G., Chawla, Y.K., Gani, R.A., Putranto, T.A., Sarin, S.K.
Published 2011